Centaurus Financial Inc. bought a new position in HCA Healthcare Inc (NYSE:HCA) during the fourth quarter, HoldingsChannel reports. The firm bought 6,306 shares of the company’s stock, valued at approximately $554,000.
Several other institutional investors and hedge funds also recently modified their holdings of HCA. BlackRock Inc. raised its holdings in HCA Healthcare by 2.0% in the 4th quarter. BlackRock Inc. now owns 22,002,879 shares of the company’s stock worth $1,932,733,000 after purchasing an additional 433,283 shares during the period. Longview Partners Guernsey LTD raised its holdings in HCA Healthcare by 8.0% in the 4th quarter. Longview Partners Guernsey LTD now owns 12,022,516 shares of the company’s stock worth $1,056,058,000 after purchasing an additional 887,361 shares during the period. APG Asset Management N.V. raised its holdings in HCA Healthcare by 6.3% in the 4th quarter. APG Asset Management N.V. now owns 3,639,381 shares of the company’s stock worth $266,225,000 after purchasing an additional 216,000 shares during the period. Victory Capital Management Inc. raised its holdings in HCA Healthcare by 11.8% in the 4th quarter. Victory Capital Management Inc. now owns 2,742,110 shares of the company’s stock worth $240,867,000 after purchasing an additional 288,758 shares during the period. Finally, American Century Companies Inc. raised its holdings in HCA Healthcare by 1.0% in the 4th quarter. American Century Companies Inc. now owns 2,582,632 shares of the company’s stock worth $226,858,000 after purchasing an additional 24,416 shares during the period. Hedge funds and other institutional investors own 74.14% of the company’s stock.
HCA Healthcare Inc (NYSE:HCA) opened at $100.35 on Thursday. HCA Healthcare Inc has a fifty-two week low of $71.18 and a fifty-two week high of $106.84. The company has a market capitalization of $35,359.29, a P/E ratio of 14.81, a price-to-earnings-growth ratio of 1.01 and a beta of 0.48. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58.
HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.25. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The business had revenue of $11.56 billion during the quarter, compared to analysts’ expectations of $11.19 billion. During the same quarter in the prior year, the firm earned $1.80 earnings per share. The business’s revenue was up 8.7% compared to the same quarter last year. equities research analysts expect that HCA Healthcare Inc will post 8.71 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 1st will be issued a dividend of $0.35 per share. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.40%.
HCA has been the subject of a number of analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $90.00 price target on shares of HCA Healthcare in a report on Tuesday, October 31st. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $82.00 price target on shares of HCA Healthcare in a report on Wednesday, November 1st. Mizuho reduced their price target on HCA Healthcare from $85.00 to $84.00 and set a “buy” rating for the company in a report on Wednesday, November 1st. Jefferies Group reduced their price target on HCA Healthcare from $90.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, November 1st. Finally, Credit Suisse Group initiated coverage on HCA Healthcare in a report on Thursday, November 2nd. They issued an “outperform” rating and a $95.00 price target for the company. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the stock. HCA Healthcare presently has an average rating of “Buy” and a consensus price target of $104.50.
In other news, insider Michael S. Cuffe sold 2,400 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $86.63, for a total value of $207,912.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CMO Jonathan B. Perlin sold 38,480 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $102.05, for a total value of $3,926,884.00. Following the completion of the sale, the chief marketing officer now owns 119,778 shares of the company’s stock, valued at $12,223,344.90. The disclosure for this sale can be found here. Insiders have sold 432,436 shares of company stock valued at $43,341,457 in the last three months. Insiders own 2.90% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/22/centaurus-financial-inc-buys-shares-of-6306-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.